Leadership change at Retrophin

|By:, SA News Editor

Retrophin (RTRX) appoints Stephen Aselage President and COO effective immediately. He will be responsible for corporate development activities including the commercialization of current products, building out the firm's global infrastructure and exploring new business development opportunities.

Mr. Aselage joined Retrophin in 2012 from BioMarin Pharmaceuticals where he was EVP and Chief Business Officer.